MapLight Therapeutics (MPLT) Liabilities and Shareholders Equity (2024 - 2025)
MapLight Therapeutics' (MPLT) quarterly Liabilities and Shareholders Equity came in at $479.5 million in Q4 2025, up 250.22% year-on-year from $136.9 million in Q4 2024, and up 86.42% quarter-over-quarter from $257.2 million in Q3 2025.
MapLight Therapeutics (MPLT) Liabilities and Shareholders Equity (2024 - 2025) Analysis & Trends
MapLight Therapeutics has disclosed Liabilities and Shareholders Equity across 2 years of filings, most recently posting $479.5 million for Q4 2025.
- Liabilities and Shareholders Equity for Q4 2025 came in at $479.5 million, up 250.22% year-over-year; the trailing twelve-month figure through Dec 2025 was $873.6 million (changed N/A YoY), and the FY2025 annual result was $479.5 million, up 250.22% from the prior year.
- Liabilities and Shareholders Equity came in at $479.5 million for Q4 2025 at MapLight Therapeutics, up from $257.2 million in the prior quarter.
- In the past five years, Liabilities and Shareholders Equity ranged from a high of $479.5 million in Q4 2025 to a low of $136.9 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 37.37 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 811.27 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 14.93 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.73 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 23.64 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 33.89 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 12.81 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 26.48 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 640.56 Mn |
| 10 | MapLight Therapeutics | 248.88 Mn | 248.88 Mn | - | 479.51 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 479.51 Mn |
| Sep 30, 2025 | 257.22 Mn |
| Dec 31, 2024 | 136.92 Mn |